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Abstract. Under physiological conditions, in vitro interaction between the antiviral drug 2,7-bis[2-
(diethylamino)ethoxy]-9-fluorenone dihydrochloride (Tilorone, TIL) and human serum albumin 
(HSA) was investigated at excitation wavelength 280 nm and at different temperatures (298 K and 
313 K) by fluorescence emission spectroscopy. TIL showed a strong ability to quench the intrinsic 
fluorescence of HSA through a static quenching procedure. The binding constant is estimated as  
KA =7.19× 104L·mol-1 at 298 K. The enthalpy change (ΔHº) and entropy change (ΔSº) were derived 
to be negative values. A value of 1.63 nm for the average distance r between TIL (acceptor) and 
tryptophan residues of HSA (donor) was derived from the fluorescence resonance energy transfer. 
________________________________________________________________________________ 
Introduction 
Drug-protein binding has become an 
important research field in life sciences, 
chemistry and clinical medicine [1]. 
Human serum albumin (HSA) serves as 
the primary transport protein in the human 
circulation capable of binding reversibly both 
endogenous and exogenous ligands such as fatty 
acids, hormones and drugs. It consists of 585 
amino acids in a single polypeptide chain [2]. 
Serum albumin is considered as a model to 
study the drug-protein interaction in vitro. It is a 
convenient protein for intrinsic fluorescence 
measurement due to the presence of tryptophan 
(Trp) residues which is highly sensitive to its 
local environment, and can be used to observe 
changes in the fluorescence emission spectra 
due to protein conformational changes and 
binding to substrates [3]. Therefore, study of the 
interaction between protein and drug molecules 
will help provide basic information on the 
pharmacological actions, bio-transformation, 
bio-distribution of drugs. The binding 
phenomena will also be useful to explain the 
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relationship between the structures and 
functions of proteins. 
There are some popular techniques which 
have been used to investigate the interaction 
between drugs and proteins. Fluorescence 
spectroscopy is one of the powerful techniques 
to study molecular interactions which changes 
local environment of fluorophore and helps to 
predict the binding phenomenon of drugs to 
proteins [4]. 
There are a number of reports in the 
literature, where binding of metabolites, drugs, 
dyes, fatty acids, bio-active-substances have 
been studied in detail. So the nature of binding 
of a ligand with HSA (BSA) is different for 
different ligands [5 - 25]. 
In this work, we provide fluorescence 
spectroscopic investigations on the effect of 
antiviral drug 2,7-bis[2-(diethylamino)ethoxy]-
9-fluorenone dihydrochloride (Tilorone, TIL) on 
the structural and optical properties of human 
serum albumin. Binding parameters, such as the 
binding constant, number of sites, binding 
distance were obtained from the fluorescence 
data. 
Experimental part 
Materials 
HSA was purchased from Sigma-
Aldrich. A 1.0.10–5 mol L–1 solution of HSA 
was prepared by dissolving 66.5 mg in 100 mL 
of water. Protein concentration was determined 
spectrophotometrically by using molar 
extinction coefficient of 36 600 mol–1·L·cm−1 at 
280 nm [26]. 
TIL solution (1.0.10–3 mol L−1) was 
prepared by dissolving 0.0484 g of substance in  
100 mL of water. The working solutions were 
obtained by diluting the stock solution with 
water. TIL (Scheme 1) was synthesized as 
described in [27] and appeared antiviral activity.  
 
 
Scheme 1. The structure of TIL 
Buffer solution was prepared by dissolving 
121.14 g tris (tris(hydroxymethyl) 
aminomethane) (Sigma-Aldrich) in 800 mL 
H2O, and adjusting the pH to 7.4 using the 
appropriate volume of concentrated HCl, 
diluting to 1000.0 mL with water (1 mol L−1).  
All of the used chemicals were of 
analytical grade or chemically pure. Also high-
purity water from Milli-Q system used in the 
performed. 
Apparatus 
Absorption spectra were recorded at room 
temperature on a UV-2401 PC UV-Vis 
spectrophotometer (Shimadzu, Japan) equipped 
with 1.0 cm quartz cells. Fluorescence spectra 
were recorded on a on Cary Eclipse 
Fluorescence spectrometer (Varian, Australia) 
equipped with a 150-W xenon lamp in a 1-cm 
quartz cell using an excitation wavelength of 
280 nm over a wavelength range of 285–475 nm 
at two temperatures (298, 313 K). The 
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excitation and emission bandwidths were  
10 nm. 
For different temperatures a thermostat 
bath (WNB 14 Memmert GmbH, Germany) was 
used. The pH values of solutions were measured 
on Lab 850 pH meter (Schott Instruments 
GmbH, Germany) with a glass electrode. 
Data were analyzed using Origin 8.0 
software (OriginLab Corporation, Northampton, 
MA, USA). 
Procedures 
1.00 mL Tris-HCl buffer, 1.0 mL of 
1.0.10–5 mol L–1 HSA solution and a appropriate 
quantities of the working TIL solution  
(1.10–4 mol L−1, 1.10–5 mol L−1) were transferred 
to a 10 mL flask. Then the solution was diluted 
to 10 mL with high-purity water. All solutions 
were mixed thoroughly and kept 5 min before 
measurements.  
The UV/vis absorbance spectra were 
recorded at room temperature. 1.00 mL Tris-
HCl buffer, 5.0 mL of 1.0.10–5 mol L–1 HSA 
solution and a appropriate quantities of the 
working TIL solution (1.10–4 mol L−1,  
1.10–5 mol L−1) were transferred to a 10 mL 
flask. Then the solution was diluted to 10 mL 
with high-purity water. A blank system for 
absorbance spectra of TIL and HAS containing 
only 1.00 mL Tris-HCl buffer and diluted to  
10 mL with high-purity water. A blank systems 
for absorbance spectra of (HSA + TIL) 
containing 1.00 mL Tris-HCl buffer, appropriate 
concentration of tilorone and diluted to 10 mL 
with high-purity water.  
Results and discussion 
UV–vis absorption spectra experiments 
UV–vis absorption measurement is a simple 
and pertinent method that is used to investigate 
structural changes and to explore complex 
formation [28]. TIL exhibited one evident peak 
at 270 nm (Figure 1, а). To initially verify the 
quenching mechanism, the UV absorption 
spectra of (HSA) and difference absorption 
spectrum between ((HSA + TIL) - TIL) were 
measured and recorded. As shown in  
Figure 1, b, HSA possessed two absorption 
peaks at 220 nm and 280 nm. The strong 
absorption peak at around 220 nm reflected the 
absorption of the backbone of HSA, while the 
weak absorption peak at around 280 nm resulted 
from the aromatic amino acids (Trp, Tyr, and 
Phe). With the addition of TIL, the intensity of 
the peak at 220 nm was changed with a red shift 
of about 2 nm, indicating disturbances to the 
microenvironment around the amide bonds in 
the protein. The results demonstrated the 
existence of an interaction between TIL and 
HSA. The absorption spectrum at around 280 
nm did not shift, indicating that the 
microenvironment around the aromatic acid 
residues was not exposed to any change upon 
HSA-TIL complexation.  
Fluorescence quenching spectra  
Any process, which decreases the 
fluorescence intensity of a sample, is called 
fluorescence quenching. 
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Figure 1. Absorption spectrum of TIL (cTIL = 2.0 × 10−5 mol L−1) (a); effect of TIL on UV 
absorption spectra of HSA (b) (T= 298 K, pH 7.4, cHSA = 5·10-6 mol L−1, cTIL×10-6 mol L−1, 1-7: 
0; 1.0; 2.0; 5.0; 7.0; 10.0; 20.0 (2-7 - difference absorption spectrum between TIL —HSA and TIL) 
The basic principles like excited state 
reactions, molecular rearrangements, energy 
transfer, ground state complex formation, and 
collisional quenching involves in molecular 
interaction, which can result in quenching. 
The interaction of TIL with HSA was 
evaluated by monitoring the intrinsic 
fluorescence intensity changes of proteins upon 
addition of TIL (Figure 2). The emission of 
HSA was characterized by a broad emission 
band at 346 nm. HSA fluorescence intensity 
decreased remarkably as TIL concentrations 
increased. TIL produced ~50% quenching in 
HSA fluorescence intensity, which was 
accompanied by a 2 nm blue shift in the 
emission maximum at the same ligand 
concentration. The shift in the emission 
maximum of HSA towards shorter wavelength 
suggested increased hydrophobicity in the 
microenvironment of the protein fluorophores 
upon interaction with this compound [29]. This 
indicated that TIL could interact with HSA. 
Analysis of the emission change of HSA 
with various amounts of TIL was carried out 
with the Stern–Volmer equation: 
qSV kQKF
F  1][10 τ0 [Q]             (1), 
where F0 and F are the fluorescence intensity in 
the absence and presence of the quencher, 
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respectively, Q the quencher concentration, and 
kq the quenching rate constant for a 
biomolecular reaction, KSV the Stern–Volmer 
quenching constant and τ0 is the average lifetime 
for fluorophore in the absence of quencher 
evaluated at 10-8 s [12]. 
 
Figure 2. Fluorescence emission spectra of 
HSA in the presence of TIL various amounts 
(cTIL (μmol L−1), curves (1-10): 0, 1.0, 2.0, 5.0, 
7.0, 10.0, 20.0, 25.0; 30.0, 35.0; pH 7.4, λex = 
280 nm, cHSA = 1·10-6 mol L−1, T= 298 K) 
 
Figure 3 shows plots of F0/F versus TIL 
concentrations at different temperatures. They 
exhibit good linear correlations. It is clear that 
plots in Fig. 3 are approximately consistent with 
the Stern–Volmer equation, from which the 
Stern–Volmer quenching constant KSV are 
derived and are listed in Table 1. 
A quenching process can be usually 
induced by a collisional process and/or a 
formation of a complex between quencher and 
fluorophore. The values for quenching rate 
constants in Table 1 are of the magnitude of 
1012 L×mol-1 s-1. 
 
Figure 3. Stern-Volmer plots for quenching of 
HSA fluorescence by TIL at different 
temperatures (pH 7.4, λex = 280 nm,  
cHSA = 1·10-6 mol L−1) 
 
Table 1. The Stern-Volmer constants, and 
quenching constants of the HSA by TIL at 
different temperatures 
T(K) KSV·× 10
-4 
(L·mol-1) R
a kq × 10-12  
(L·mol-1 s-1) 
298 3.23 0.9978 3.23 
313 2.07 0.9949 2.07 
a correlation coefficient 
Obviously, the quenching rate constant kq 
for TIL–HSA is greater than that of a scatter 
process. It may be attributed a quenching 
process initiated by bio-active substances. So it 
shows that the above quenching was not 
initiated by dynamic collision but forms 
compound, it was static quenching. 
Furthermore, linear Stern–Volmer plots 
may either reveal the occurrence of just a 
binding site for quencher in the proximity of the 
fluorophore or indicate the existence of a single 
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type of quenching [31]. 
When small molecules are bound 
independently to a set of equivalent sites on a 
macromolecule, the binding constant (KA) and 
sites (n) can be derived from the Eq. (2) [16]: 
]log[loglog 0 QnK
F
FF
A 

            (2), 
where F0 and F are the fluorescence intensity in 
the absence and presence of bio-active 
substance, respectively. 
They still display good linear correlations. 
The values for KA and n derived from plots in 
Fig. 3 according to Eq. (2) are collected in 
Table 2. 
Table 2. Binding constant KA, the number of binding sites n and distance between acceptor and 
donor r at different temperatures and thermodynamic parameters of TIL-HSA interaction at pH 7.4 
(λex = 280 nm) 
T(K) KA·× 10-4 (L·mol-1) n r 
ΔHº 
(kJ·mol-1) 
ΔGº 
(kJ·mol-1) 
ΔSº 
(J·mol-1·K-1) 
298 7.19 1.08 1.63 
-33.64 
-27.71 
-19.91 
313 3.75 1.05 1.66 -27.41 
 
They indicate that the amount of TIL will 
affect the pattern of TIL binding to HSA. The 
influence of temperatures on the TIL binding to 
HSA is significant. It is obvious that higher 
temperature will lead to a rapid collision, 
whereas results in a decrease in the binding 
strength. As a result, KA and n will decrease 
with raising temperature. 
Furthermore, the value for n close to one, 
we may infer that there exists only one kind of 
binding site on HSA for TIL binding 
(determined by this method).  
Collectively, the fluorescence quenching of 
HSA by drug was caused by the static 
quenching, which supported the HSA UV 
spectral shifts [30]. 
Binding mode 
The interaction of BSA and small drug 
molecules may involve hydrophobic forces, 
electrostatic forces, van der Waals, hydrogen 
bonds and other interactions. The signs and 
magnitudes of thermodynamic parameters for 
protein reactions can be accounted for the main 
forces contributing to protein stability. The 
values for the enthalpy change (ΔHº) and 
entropy change (ΔSº) will be derived from the 
van’t Hoff equation by considering ΔHº not 
varying significantly over the experimental 
temperature range: 
R
S
RT
HK A
ln                           (3),  
where KA is the binding constant at a definite 
temperature T and R is the gas constant. 
Consequently, the amount of free energy change 
ΔGº required for the binding is estimated from 
the following equation: 
 STHG                               (4) 
From the enthalpy change (ΔHº) and 
entropy (ΔSº), the mode of interaction can be 
assessed. It is suggested that if ΔHº > 0 and ΔSº 
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> 0, hydrophobic interaction occurs, and if ΔHº 
< 0 and ΔSº < 0, Van der Waals and hydrogen 
bonds dominates, and if ΔHº < 0 and ΔSº > 0, is 
due to electrostatic forces [32]. The data for ΔHº 
and ΔSº of TIL binding to HSA are listed in 
Table 2. With respect to recognized literature 
data on analogous systems [19,33], the negative 
values of  ΔHº and ΔSº can be attributed in part 
to van der Waals forces and in part to the 
formation of hydrogen bonds. 
Energy transfer from HSA to TIL 
Fluorescence resonance energy transfer 
(FRET) is a distance–dependent interaction 
between the different electronic excited states of 
molecules. In this interaction, excitation energy 
is transferred from one molecule (donor) to 
another (acceptor) through direct 
electrodynamic interaction, without emission of 
a photon from the former molecular system 
[34]. Energy transfer may occur under the 
following conditions: when the donor can 
produce fluorescent light; when there is an 
overlap between the fluorescence emission 
spectrum of the donor and the absorbance 
spectrum of the acceptor; and when the distance 
between the donor and the acceptor is less than  
8 nm. The efficiency of energy transfer between 
TIL and the HSA Trp214 residue could be used 
to evaluate the distance between the two using 
FRET. The overlap of the absorbance spectrum 
of TIL with the fluorescence emission spectrum 
of HSA has been shown in Figure 4. 
According to Forster’s non-radiative 
resonance energy transfer theory [35], energy 
transfer efficiency E is related not only to the 
distance (r) between the bound bio-active 
molecule (acceptor) and the protein residue 
(donor), but also to the critical energy transfer 
distance (R0). 
 
Figure 4. Overlap of the absorption spectrum of 
TIL (1) with the fluorescence emission 
spectrum of HSA (2) (cHSA/cTIL = 1:4,  
5·10-6 mol L−1; T = 298 K ; λex = 280 nm) 
 
By Forster’s theory, the efficiency of 
energy transfer (E) can be calculated according 
to the following equation: 
)/(/1 660
6
00 rRRFFE                         (5), 
where r is the distance between acceptor (TIL) 
and donor (HSA), and R0 is the critical distance 
when the transfer efficiency is 50%. The value 
of R0 is calculated using the following equation:  
JnKR 422560 1079.8                              (6), 
where K2 is the spatial orientation factor of the 
dipole; n is the refractive index of the medium; 
φ is the fluorescence quantum yield of donor; 
and J is the spectral overlap between the 
emission spectrum of donor and the absorption 
spectrum of acceptor (Figure 4), given by: 
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where F(λ) is the normalized fluorescence 
intensity of the donor at wavelength λ, and ε(λ) 
is the molar absorption coefficient of the 
acceptor at wavelength λ. In the present case, K2 
= 2/3, n = 1.336, and φ = 0.118 [36]. Hence, 
from equations (5)–(7), we could calculate the 
following parameters are listed in Table 3. 
In conclusion, the distance (r) between HSA 
Trp214 and bound TIL was much less than 8 
nm, and accorded with the relationship 0.5R0 < r 
<1.5R0. This implied that the non-radiative 
energy transfer from HSA to TIL occurred with 
high possibility, which was in accordance with 
the occurrence of a static quenching mechanism. 
This result indicated that the binding obeyed the 
conditions of Forster’s energy transfer. A 
comparison of the J, R0 and r values of different 
ligands bound to proteins is given in Table 3. 
 
Table 3. Comparative assessment of the TIL (ligand) distance to protein’s fluorophore (HSA) 
measured by Forster’s nonradiative energy transfer with other ligands bound to proteins 
Ligand Protein J (cm3 L mol−1) R0 (nm) r (nm) References 
mitoxantrone HSA 1.67×10−15 0.48 2.64 [5] 
imidacloprid HSA 3.17 × 10–15 1.52 2.10 [6] 
captopril HSA 1.09 × 10–18 2.37 1.05 [7] 
pyrimidine-annulated  
spiro-dihydrofuran 
BSA 9.14 × 10–16 1.71 2.59 
[8] 
eupatorin BSA 1.79 × 10–14 1.56 1.64 [9] 
erlotinib hydrochloride BSA 3.89 × 10–21 2.00 2.20 [10] 
sanguinarine BSA 1.29 × 10–14 2.63 2.38 [11] 
carbamazepine BSA 3.24 × 10–15 2.11 3.60 [12] 
naringin BSA 3.24 × 10–15 2.32 3.25 [13] 
3-carboxyphenoxathiin BSA 1.63 × 10–15 1.86 1.86 [14] 
paclobutrazol HSA 1.35×10−14 2.58 4.41 [15] 
pazufloxacin mesilate BSA 9.93 × 10–15 2.45 4.04 [16] 
benzidine trypsin 3.92 × 10–15 2.67 2.97 [17] 
nevadensin lysozyme 8.17 × 10–15 2.41 2.28 [18] 
farrerol lysozyme 5.19 × 10–14 2.07 2.67 [19] 
fosfomycin BSA 1.87 × 10–14 2.83 4.99 [24] 
sulfamethoxazole HSA 1.70 × 10–16 2.79 3.89 [25] 
tilorone (presented study) HSA 7.88× 10–16 1.67 1.63 this work 
Conclusions 
In this work, the interaction between TIL 
and serum albumin (HSA) have been  
investigated by fluorescence method combined 
with UV–vis spectroscopy techniques under 
simulative physiological condition. The 
experiment results indicate that TIL quenches 
the intrinsic fluorescence of proteins through 
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static quenching mode of TIL-HSA system, 
which supported the HSA UV spectral shifts 
and the decreasing binding constant for TIL and 
HSA complex with increasing temperature 
indicates the decomposition of the system. 
The values of binding constant and the 
number of binding sites of the TIL-HSA system 
are determined using the Stern-Volmer 
equation. The average binding distance between 
donor and acceptor molecules is found to be 
1.63 nm for HSA - TIL systems from the 
Forster non-radioactive resonance energy 
transfer theory. 
Since, the pharmaceutical firms need 
standardized screens for protein binding in the 
first step of new drug design, this kind of study 
of interaction between HSA with TIL would be 
useful in pharmaceutical industry and clinical 
medicine. 
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